NCT07167004 The GRoceries Aimed at Increasing Nutrition Study
| NCT ID | NCT07167004 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 216 participants |
| Start Date | 2025-10-14 |
| Primary Completion | 2027-02-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 216 participants in total. It began in 2025-10-14 with a primary completion date of 2027-02-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Only 2% of Americans meet the recommended levels of whole grain consumption, despite its association with reduced risk of type 2 diabetes. This study aims to assess if consumers with prediabetes or type 2 diabetes can be encouraged to switch from buying refined grain products to whole grain products when shopping for groceries online. The study will use personalized marketing strategies, with or without discounts which adjust based on purchasing behavior, to promote whole grain consumption.
Eligibility Criteria
Inclusion Criteria: * Age 45 - 70 years. * Able to provide consent. * Resident of Philadelphia, Bucks, Delaware, Chester, or Montgomery Counties in Pennsylvania. * Consume \<5 servings of whole grains per week. * Use online grocery shopping at least once per month. * Have access to a credit or debit card to pay for groceries purchased. * Have reliable internet access. * Speak English. * Penn Medicine patient diagnosed with prediabetes or diabetes (identified using ICD-10 codes R73.03, E11). Exclusion Criteria: * Does not meet all the inclusion criteria. * Not able to speak English. * Not able to provide consent.
Contact & Investigator
Sophia V Hua, PhD, MPH
PRINCIPAL INVESTIGATOR
Department of Medical Ethics and Health Policy, Perelman School of Medicine
Frequently Asked Questions
Who can join the NCT07167004 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 70 Years, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07167004 currently recruiting?
Yes, NCT07167004 is actively recruiting participants. Contact the research team at Emily.Dzieniszewski@Pennmedicine.upenn.edu for enrollment information.
Where is the NCT07167004 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07167004 clinical trial?
NCT07167004 is sponsored by University of Pennsylvania. The principal investigator is Sophia V Hua, PhD, MPH at Department of Medical Ethics and Health Policy, Perelman School of Medicine. The trial plans to enroll 216 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.